SEQUENTIAL HEMIBODY IRRADIATIONS
\siːkwˈɛnʃə͡l hˈɛmɪbˌɒdi ˌɪɹe͡ɪdɪˈe͡ɪʃənz], \siːkwˈɛnʃəl hˈɛmɪbˌɒdi ˌɪɹeɪdɪˈeɪʃənz], \s_iː_k_w_ˈɛ_n_ʃ_əl h_ˈɛ_m_ɪ_b_ˌɒ_d_i_ ˌɪ_ɹ_eɪ_d_ɪ__ˈeɪ_ʃ_ə_n_z]\
Sort: Oldest first
-
Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called "systemic" hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p2210, 1985)
By DataStellar Co., Ltd
Word of the day
Platidiam
- An inorganic water-soluble platinum complex. After undergoing hydrolysis, it reacts DNA produce both intra interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity cisplatin correlates with cellular arrest in G2 phase cell cycle.